ACT CAPITAL MANAGEMENT, LLC - CARDIFF ONCOLOGY INC ownership

CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 59 filers reported holding CARDIFF ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.28 and the average weighting 0.0%.

Quarter-by-quarter ownership
ACT CAPITAL MANAGEMENT, LLC ownership history of CARDIFF ONCOLOGY INC
ValueSharesWeighting
Q3 2022$186,000
-29.8%
120,6000.0%0.26%
-30.7%
Q2 2022$265,000
-11.4%
120,6000.0%0.37%
+17.4%
Q1 2022$299,000
-51.5%
120,600
+17.7%
0.32%
-29.0%
Q4 2021$616,000
-9.8%
102,5000.0%0.44%
+25.7%
Q3 2021$683,000
+0.1%
102,5000.0%0.35%
+1.1%
Q2 2021$682,000102,5000.35%
Other shareholders
CARDIFF ONCOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 120,600$299,0000.32%
Artal Group S.A. 750,000$1,860,0000.08%
Eventide Asset Management 1,467,922$3,640,0000.06%
Atom Investors LP 33,798$84,0000.04%
XTX Topco Ltd 25,154$62,0000.03%
ELKHORN PARTNERS LIMITED PARTNERSHIP 19,000$47,0000.02%
Engineers Gate Manager LP 245,567$609,0000.02%
GSA CAPITAL PARTNERS LLP 63,749$158,0000.02%
KENNEDY CAPITAL MANAGEMENT LLC 168,902$419,0000.01%
Walleye Capital LLC 123,305$306,0000.01%
View complete list of CARDIFF ONCOLOGY INC shareholders